4D Medicine raises £3.4 million for unique biomaterial platform
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment. ...
Alden Thornbury covers biotechnology and bioengineering, including gene therapy, biomaterials, synthetic biology, tissue engineering, and translational bioinnovation.
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment. ...
Researchers at the University of Cambridge demonstrate that the plant hormone gibberellin (GA) is essential for the formation and maturation...
Long before photosynthesis brought free oxygen into the world, the earth was already populated by numerous organisms. Oxygen was life-threatening...
The field of synthetic biology, the science of manipulating biology, has a lot of “cooks in the kitchen,” which has...
The Korea Research Institute of Standards and Science (KRISS) has developed the world’s first organoid culture method capable of accurately...
In the latest study, researchers have successfully demonstrated a novel biosensor capable of detecting single-stranded DNA oligonucleotides with high specificity...
Oak Brook, IL – Volume 29, Issue 2 of SLAS Technology, includes three original research articles covering skin cutaneous melanoma,...
The rapid adoption of AI and big data technologies in the biotechnology sector presents unique data privacy and security challenges....
Michelle Chen, Ph.D., Chief Business Officer of clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine (“Insilico”) was named...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine